The marker "CD16+ or CD56+/ CD3+" refers to a subset of immune cells that express CD16 or CD56 surface proteins along with CD3. These markers are typically associated with a specific type of T cell known as NKT (Natural Killer T) cells. NKT cells are unique because they share properties of both NK cells and conventional T cells, playing a versatile role in the immune system.
CD16 and CD56: These are markers commonly found on NK cells, which are part of the innate immune system. CD16 is a receptor that allows these cells to recognize and destroy antibody-coated target cells, while CD56 is an adhesion molecule that facilitates cell-cell interactions and migration.
CD3: This is a marker that is characteristic of T cells, specifically associated with the T-cell receptor (TCR) complex. The presence of CD3 indicates that these cells have T-cell lineage, allowing them to participate in adaptive immune responses.
When immune cells are "CD16+ or CD56+ CD3+", it implies they are a specialized subset that can respond quickly to infected or transformed cells, combining the rapid, non-specific response typical of NK cells with the specific, adaptive responses characteristic of T cells. These cells play roles in immune regulation, autoimmune disease responses, cancer surveillance, and infection defense. Understanding the presence and levels of CD16+ or CD56+ CD3+ cells can provide insights into the state of the immune system, especially in contexts such as autoimmune diseases, cancer immunology, and infectious diseases.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.